The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,981.00
Bid: 1,985.00
Ask: 1,987.00
Change: 8.00 (0.41%)
Spread: 2.00 (0.101%)
Open: 1,967.00
High: 1,989.00
Low: 1,966.00
Prev. Close: 1,973.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: Stocks called up following slew of FTSE 100 earnings

Thu, 29th Feb 2024 07:45

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, after a slew of earnings from a range of FTSE 100 companies.

Eyes are firmly on a key US inflation reading on Thursday. According to FXStreet-cited consensus, the headline annual personal consumption expenditures inflation rate is to ease to 2.4% in January, from 2.6% in December. The core reading, the Fed's preferred inflationary gauge, is to ebb to 2.8% from 2.9%.

"The Fed will probably cut the rates this year, yet a cut before summer won't be on the agenda if inflation doesn't continue to ease. Three Fed members repeated yesterday that the timing and the pace of policy easing will depend on data. Activity on Fed funds futures gives around 64% chance for a June cut before the data. Bets could go either way. A figure in line or ideally softer than expected should keep the FEd doves betting for the first rate cut to happen in June, whereas a stronger-than-expected figure could strengthen the hawks' hand and push the expectation of the first cut to… July," said Ipek Ozkardeskaya, senior analyst at Swissquote Bank.

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: called up 0.2% at 7,637.60

----------

Hang Seng: up 0.3% at 16,584.83

Nikkei 225: closed down 0.1% at 39,166.19

S&P/ASX 200: closed up 0.5% at 7,698.70

----------

DJIA: closed down 23.39 points, 0.1%, at 38,949.02

S&P 500: closed down 8.42 points, 0.2%, to 5,069.76

Nasdaq Composite: closed down 87.56, 0.6%, at 15,947.74

----------

EUR: down at USD1.0833 (USD1.0835)

GBP: up at USD1.2659 (USD1.2656)

USD: down at JPY149.69 (JPY150.73)

Gold: up at USD2,036.89 per ounce (USD2,033.68)

(Brent): up at USD81.86 a barrel (USD81.78)

(changes since previous London equities close)

----------

ECONOMICS

----------

Thursday's key economic events still to come:

08:30 EST Canada GDP

07:30 CET France nonfarm payrolls

08:45 CET France CPI

08:45 CET France GDP

08:45 CET France household consumption

08:45 CET France PPI

08:00 CET Germany retail sales

09:55 CET Germany unemployment

13:00 CET Germany CPI

11:00 GMT Ireland CPI

10:00 CET Italy industrial sales

09:00 CET Spain CPI

10:00 CET Spain current account

09:00 CET Switzerland GDP

09:00 CET Switzerland KOF leading indicators

09:30 GMT UK mortgage approvals

08:30 EST US personal consumption expenditures

08:30 EST US initial jobless claims

09:45 EST US Chicago PMI

10:00 EST US pending home sales

10:30 EST US EIA natural gas stocks

11:00 EST US Kansas City Fed composite index

11:00 EST US Kansas City Fed manufacturing index

12:00 EST US 15-year fixed rate mortgage average

20:10 EST US New York Fed President John Williams speaks

----------

UK house sales were 15% higher in recent weeks than the same period a year ago as mortgage rates started to fall, a new survey has suggested. Zoopla found that agreed sales jumped as demand from buyers was up by 11% and the number of homes for sale 21% higher than a year ago. The survey, which covers the four weeks to February 18, found that house prices only dropped 0.5% compared to a year earlier. The reduction has mellowed since October when prices dropped 1.4% on average across the UK. "The housing market has proved very resilient to higher mortgage rates and cost of living pressures," said Zoopla executive director Richard Donnell. "More sales and more sellers shows growing confidence amongst households and evidence that 4-5% mortgage rates are not a barrier to improving market conditions."

----------

BROKER RATING CHANGES

----------

RBC raises Hikma Pharma price target to 2,375 (2,175) pence - 'sector perform'

----------

Jefferies cuts Rio Tinto price target to 6,000 (6,500) pence - 'buy'

----------

Berenberg cuts Reckitt price target to 5,800 (6,240) pence - 'hold'

----------

COMPANIES - FTSE 100

----------

London Stock Exchange said total income in 2023 climbed 8.2% to GBP8.38 billion from GBP7.74 billion a year earlier. Pretax profit fell 3.7% to GBP1.20 billion from GBP1.24 billion. On the back of the results, LSEG upped its dividend by 7.5% to 115.0p from 107.0p. It also said it plans to execute up to GBP1 billion of buybacks in 2024. In 2023, the company returned GBP1.2 billion through buybacks. CEO David Schwimmer said: "2023 was another strong year for LSEG. We continued our track record of broad-based growth, despite an uncertain environment, and delivered on all the targets we set at the time of the Refinitiv acquisition. We also significantly improved our products and services, further strengthened our leadership team and made great progress on creating a high-performance culture throughout the organisation."

----------

Howden Joinery reported revenue of GBP2.31 billion in 2023, down 0.3% from GBP2.32 billion a year earlier. Pretax profit dropped 19% to GBP327.6 million from GBP405.8 million. It said that this included GBP17 million of additional costs relating to a 53rd week, before these costs pretax profit was down 15%. On the back of the results, Howden upped its dividend by 1.9%, bringing the total dividend for the year to 21.0p, up from 20.6p. Looking ahead, the company said it is on track with its outlook for 2024. CEO Andrew Livingston said: "Our robust balance sheet underpins our strategy as we invest in growth, including expanding our manufacturing and supply chain capabilities, and returning surplus capital to shareholders. While we are cautious about the macro-economic and geo-political environment, given the encouraging start to the year and the agility of our business model, the Board is confident in the outlook for 2024."

----------

COMPANIES - FTSE 250

----------

Spire Healthcare reported a 13% increase in revenue to GBP1.36 billion from GBP1.20 billion a year earlier. Pretax profit surged to GBP34.6 million from GBP3.9 million. On the back of the results, upped its final dividend to 2.1p, from 0.5p. Since the year end, Spire Healthcare said it has continued to trade in line with management expectations. It added that management remains confident of reaching the medium-term targets. CEO Justin Ash said: "This is a strong set of results, delivered during a period of macroeconomic uncertainty and in an inflationary environment, demonstrating that our strategy and execution is working. The high-quality diagnosis and treatment we provide in our hospitals continued to meet the demand for fast access to care throughout 2023, while we broadened our range of services to meet more of people's healthcare needs out-of-hospital, in the community and at home. This enabled us to care for over one million patients for the first time, over the year." Separately, Spire Healthcare said its Chief Financial Officer Jitesh Sodha has decided to step down after five years. He will step down following the company's annual general meeting, to be held in May. Following this he will continue in the business reporting to CEO Justin Ash until February 2025 to ensure a smooth transition for the company and to support a number of strategic initiatives and projects. It also named Deputy CFO Harbant Samra as is new finance chief.

----------

OTHER COMPANIES

----------

Seplat Energy reported results for 2023. In the year, revenue climbed to USD1.06 billion, up 12% from USD951.8 million a year earlier. Pretax profit fell 6.4% to USD191.2 million from USD204.4 million. The total dividend for the year was lifted to 15 US cents. Production averaged 47,758 barrels of oil per day, up 8.3% from 44,104 boepd recorded in 2022, and within original guidance. For 2024, Seplat is guiding for production to be between 44 kboepd and 52 kboepd .

----------

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
6 Mar 2023 09:48

LONDON BROKER RATINGS: DB cuts Reckitt; Jefferies likes Tesco

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
1 Mar 2023 09:52

LONDON BROKER RATINGS: Canaccord says sell Future; Investec likes RWS

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
27 Feb 2023 09:38

Berenberg raises target price on Hikma Pharmaceuticals

(Sharecast News) - Analysts at Berenberg raised their target price on drugmaker Hikma Pharmaceuticals from 1,440.0p to 1,740.0p on Monday on the back of the group's recent trading update.

Read more
27 Feb 2023 09:26

LONDON BROKER RATINGS: Citi cuts Quilter to 'sell'; Goldman likes GSK

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
24 Feb 2023 09:37

LONDON BROKER RATINGS: SocGen cuts Burberry; BofA cuts WH Smith

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
23 Feb 2023 09:54

Hikma Pharmaceuticals profit halves in 2022 on Generics impairment

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reported a dip in annual revenue for 2022, as profit tumbled due to high inflation and adjustments regarding expectations for its Generics business.

Read more
23 Feb 2023 09:02

LONDON MARKET OPEN: Mixed open in London; Rolls-Royce up, Mondi down

(Alliance News) - Stock prices in London opened mixed on Thursday, with large-cap indices underperforming amid mixed corporate earnings.

Read more
23 Feb 2023 07:59

Competition in generics sees Hikma Pharmaceuticals's profits decline by a tenth

(Sharecast News) - Hikma Pharmaceuticals posted lower full-year profits as stiff competition in generics saw its top line growth flatten out.

Read more
23 Feb 2023 07:56

LONDON BRIEFING: WPP profit jumps in 2022; guides for further growth

(Alliance News) - Stocks in London were called to open slightly higher on Thursday, as investors were unfazed by a fairly uneventful set of policy meeting minutes from the US central bank.

Read more
22 Feb 2023 21:50

Hikma accuses Amarin of suppressing generic versions of heart pill

Hikma claims Amarin used exclusive agreements with suppliers to frustrate generic rivals

*

Read more
16 Feb 2023 15:49

UK earnings, trading statements calendar - next 7 days

Friday 17 February 
Allianz Technology Trust PLCFull Year Results
Kingspan Group PLCFull Year Results
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
Monday 20 February 
Bank of Cyprus Holdings PLCFull Year Results
Georgia Capital PLCFull Year Results
Goldplat PLCFull Year Results (TBC)
LungLife AI IncFull Year Results
Tristel PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 21 February 
Antofagasta PLCFull Year Results
BHP Group LtdHalf Year Results
Blancco Technology Group PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
HSBC Holdings PLCFull Year Results
InterContinental Hotels Group PLCFull Year Results
Safestore Holdings PLCTrading Statement
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Trifast PLCTrading Statement
Wednesday 22 February 
Avingtrans PLCHalf Year Results
City of London Investment Group PLCHalf Year Results
Conduit Holdings LtdFull Year Results
Liberty Global PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Primary Health Properties PLCFull Year Results
Renewables Infrastructure Group LtdFull Year Results
Rio Tinto PLCFull Year Results
Synectics PLCFull Year Results
TBC Bank Group PLCFull Year Results
Transense Technologies PLCHalf Year Results
Thursday 23 February 
Anglo American PLCFull Year Results
Arbuthnot Banking Group PLCTrading Statement
BAE Systems PLCFull Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Drax Group PLCFull Year Results
Driver Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Made Tech Group PLCHalf Year Results
Mondi PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
Versarien PLCFull Year Results
WPP PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
25 Jan 2023 09:33

LONDON BROKER RATINGS: Goldman likes UK banks; HSBC cuts Dr Martens

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
18 Jan 2023 15:07

Director dealings: Hikma Pharmaceuticals director snaps up shares

(Sharecast News) - Hikma Pharmaceuticals revealed on Wednesday that non-executive director Deneen Vojta had acquired 1,000 ordinary shares in the FTSE 250-listed drugmaker.

Read more
12 Jan 2023 17:55

Arecor transfers AT307 drug to Hikma for development, regains AT282

(Alliance News) - Arecor Therapeutics PLC on Thursday said it transferred development activities for the ready-to-use injectable medicine AT307 to Hikma Pharmaceuticals PLC, and regained rights on AT282 after a product portfolio review.

Read more
3 Jan 2023 17:31

FTSE 100 ends first trading day of 2023 on upbeat note

FTSE 100 up 1.4%, FTSE 250 adds 1.5%

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.